§ 13F · FUND PROFILE
CAXTON CORP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 11Turnover · — · Q4Filed · Feb 13, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$4.3T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 13, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | GLD | SPDR GOLD TR | 7K | $2.8T | 64.5% | NEW |
| 2 | BRK/B | BERKSHIRE HATHAWAY INC DEL | 710 | $356.8B | 8.3% | NEW |
| 3 | SYRE | SPYRE THERAPEUTICS INC | 9K | $292.2B | 6.8% | NEW |
| 4 | BRD1EUR | MIND MEDICINE MINDMED INC | 16K | $210.1B | 4.9% | NEW |
| 5 | KYTX | KYVERNA THERAPEUTICS INC | 19K | $176.5B | 4.1% | NEW |
| 6 | CMPX | COMPASS THERAPEUTICS INC | 29K | $158.4B | 3.7% | NEW |
| 7 | LXEO | LEXEO THERAPEUTICS INC | 14K | $138.5B | 3.2% | NEW |
| 8 | XFOR | X4 PHARMACEUTICALS INC | 16K | $62.2B | 1.5% | NEW |
| 9 | IKT | INHIBIKASE THERAPEUTICS INC | 28K | $58.3B | 1.4% | NEW |
| 10 | SABS | SAB BIOTHERAPEUTICS INC | 11K | $39.4B | 0.9% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE CAXTON SIGNAL
AC read
CAXTON CORP is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed